title: [The course of post-streptococcal glomerulonephritis depending on methods of treatment for the preceding respiratory tract infection].
abstract: The aim of our work was to assess the course of post-streptococcal glomerulonephritis (APSGN) in children according to the way of preceding respiratory tract infection treatment. The examinations were carried out in a group of 26 children aged 5-15 years, who were divided into two subgroups: I--12 children, who did not receive antibacterial treatment, and II--14 children who were shortly treated with different antibiotics (3-5 days). All the children had full symptomatic picture of post-streptococcal glomerulonephritis with haematuria, oedemas, hypertension and hypocomplementemia. The etiology was diagnosed retrospectively during observation of ASO titer dynamics and additionally in 18 after finding pathogenic Streptococcus strains in pharyngeal swab. The differences in the course of illness was shown only during first weeks. In children from the group I the course of acute APSGN was a little more serious, because haematuria, proteinuria and hypertension were observed longer. Symptoms of nephrotic syndrome were observed in two children, acute renal insufficiency in two children, and one with hypertensive encephalopathy. After 3 and 12 months no children had pathological signs. Erythrocyturia was observed in 19 of 26 children after 3 months and in 10 of 26 children after 12 months after illness with similar frequency in both groups. In 5 children with proteinuria renal biopsy showed mesangialis proliferative glomerulonephritis--1st degree.
  
  
  CONCLUSIONS
  All observed children with APSGN were not cured properly during the respiratory tract infection preceding the disease, however even short antibacterial treatment caused the moderation of symptoms.
authors.affiliation: I Kliniki Chorób Dzieci Akademii Medycznej w Białymstoku.
authors.forename: W
authors.initials: W
authors.lastname: Zoch-Zwierz
authors.forename: A
authors.initials: A
authors.lastname: Wasilewska
authors.forename: A
authors.initials: A
authors.lastname: Biernacka
authors.forename: B
authors.initials: B
authors.lastname: Tomaszewska
authors.forename: W
authors.initials: W
authors.lastname: Winiecka
authors.forename: R
authors.initials: R
authors.lastname: Wierciński
authors.forename: T
authors.initials: T
authors.lastname: Porowski
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000145:classification* / Q000209:etiology*; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000209:etiology; D011379:Prognosis; D012141:Respiratory Tract Infections / Q000150:complications* / Q000188:drug therapy; D012189:Retrospective Studies; D013290:Streptococcal Infections / Q000150:complications* / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents